Search for: "BRISTOL MYERS SQUIBB"
Results 761 - 780
of 866
Sort by Relevance
|
Sort by Date
15 Oct 2008, 8:38 am
AAJ obtained emails that list attendees of a meeting between Bradshaw and the Pharmaceutical Research and Manufacturers of America (PhRMA) revealing the FDA chief counsel met with legal representatives from Pfizer, Wyeth, Eli Lilly, Berlex, Organon, Abbott Laboratories, Takeda, Sanofi-Aventis, Serono, AstraZeneca, Cephalon, Millenium, Eisai, Amgen, Astellas, GlaxoSmithKline, Bristol Myers Squibb, Johnson & Johnson, Novartis, Merck, and 3M.Less than six months after… [read post]
6 Oct 2008, 12:46 pm
The $70-per-share bid, which boards of both companies have approved, beat out an offer of $62 a share from Bristol-Myers Squibb, which markets ImClone's cancer drug Erbitux in the United States along with ImClone. [read post]
29 Sep 2008, 8:14 pm
Universities Allied for Essential Medicines (UAEM)1 is a non-profit organization that works with faculty and student groups to help ensure the availability of essential medicines in poor countries.2 Among other activities, UAEM hopes to persuade universities to commit to the principle that when they license university-developed medical-related technologies to private companies, a condition of the license will be that the private company agree to make medicines that are created using the… [read post]
19 Sep 2008, 6:00 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
11 Sep 2008, 2:42 pm
" It is also interesting to note that on July 2, 2002, the US patent Office granted Patent #US 6,413,969 (Assignee: Bristol-Myers Squibb Co.) for a new process for scaling up Tequin production. [read post]
10 Sep 2008, 9:32 pm
Recall That Bristol-Myers Had Said Decline In Sales Was Reason For Its Decision To Stop Selling Tequin (Posted by Tom Lamb at DrugInjuryWatch.com) On September 2, 2008 the FDA issued a Notice entitled "Determination That TEQUIN (Gatifloxacin) Was Withdrawn From Sale for Reasons of Safety or Effectiveness" which provides (and confirms) the real reason that Bristol-Myers Squibb Co. [read post]
10 Sep 2008, 6:00 pm
The issue came up in In re Bristol Myers Squibb Co. [read post]
10 Sep 2008, 1:59 pm
That easily tops the $60-per-share cash bid that Bristol-Myers Squibb made in [...] [read post]
23 Aug 2008, 1:23 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
16 Aug 2008, 2:43 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
7 Aug 2008, 11:45 am
Icahn may have some tricks up his sleeve to persuade Bristol-Myers Squibb to raise its $60-per-share offer for ImClone Systems, Forbes says. [read post]
4 Aug 2008, 1:22 pm
ImClone Systems, the maker of the anti-cancer drug Erbitux, said on Monday that while it is studying a $4.5 billion takeover bid from Bristol-Myers Squibb, it believes the offer is too low. [read post]
24 Jul 2008, 11:36 am
Bristol Myers Squibb, No. 07-2723 (7/23/08) affirms a grant of summary judgment (first rejected by a magistrate judge) to the defendant in a gender discrimination case. [read post]
17 Jul 2008, 8:34 pm
In addition to Fed Ex, other companies that, following my shareholder proposals, agreed to amend their bylaws to incorporate pill-limiting provisions are JCPenney, Safeway, CVS Caremark, Disney, and Bristol-Myers Squibb. [read post]
17 Jul 2008, 12:11 am
Bristol-Myers Squibb is starting to send out the $500 million refunds to the state governments it ripped off. [read post]
10 Jul 2008, 5:31 pm
Bristol-Myers Squibb Co., 121 F. [read post]
3 Jul 2008, 8:18 pm
Among the largest false-claims cases to date are a $650 million settlement earlier this year by drugmaker Merck in connection with an alleged failure to repay Medicaid rebates and a $515 million deal with Bristol-Myers Squibb to cover illegal drug pricing and marketing.Help from Justice greatly enhances the chances that a complicated fraud scheme can be unraveled, lawyers say. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at… [read post]
18 Jun 2008, 12:26 pm
Bristol-Myers Squibb [read post]
10 Jun 2008, 8:19 am
Bristol-Myers Squibb Co.U.S. [read post]
